Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01558 HEC CJ PHARM
RTNominal unchange 0.000 (0.000%)
Others

27/12/2024 16:11

{I-bank focus}Morgan lowers HEC CJ Pharma (01558) to HKD12.6

[ET Net News Agency, 27 December 2024] Morgan Stanley lowered the target price for HEC
CJ Pharma (01558) to HKD12.6 from HKD13.8 and maintained the "overweight" rating.
The research house said in light of weak flu incidence data in 4Q2024, it lowers
2024-2030 earnings estimates by 9-11% on lower antiviral sales. (rc)

Back to Others

Next︰12/12/2024 08:45  Summary of listed companies announcements (5)

Other Others
More

06/12/2024 08:45  Summary of listed companies announcements (4)

26/11/2024 08:45  Summary of listed companies announcements (4)

13/11/2024 08:45  Summary of listed companies announcements (4)

06/11/2024 08:45  Summary of listed companies announcements (4)

01/11/2024 08:45  Summary of listed companies announcements (5)

Remark: Real time quote last updated: 02/01/2025 07:38
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.